News
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Innovative Industrial Properties Declares Second Quarter 2025 Dividends
Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR), the first and only real estate company on the New York Stock Exchange focused on the regulated U.S. cannabis industry, announced today
Philip Morris International Declares Regular Quarterly Dividend of $1.35 Per Share
Regulatory News:
The Board of Directors of Philip Morris International Inc. (PMI) (NYSE: PM) today declared a regular quarterly dividend of $1.35 per common share, payable on July 15, 2025, to
EQS-Adhoc: APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40
MaaT Pharma Presents Updated Positive Data in Early Access Program for Xervyteg® at the EHA Congress Validating High Efficacy Observed in Pivotal ARES Study in Acute Graft-versus-Host Disease
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to
EQS-News: The Platform Group begins entry into the optician industry
EQS-Adhoc: The Platform Group AG: Start of entry into the optician and hearing acoustics market through the acquisition of two groups of companies with 30 locations
Notice Regarding Conviction of Three Chinese Companies That Produced and Sold Counterfeit Yamaha PA Analog Mixers
Yamaha Corporation (hereinafter “Yamaha”) (TOKYO:7951) announces that on March 20, 2025, the Zhongshan Intermediate People's Court of Guangdong Province upheld the first-instance guilty verdicts in
Fifth Third Bancorp Announces Cash Dividends
Today, Fifth Third Bancorp announced the declaration of cash dividends on its common shares, Series H preferred shares, Series I preferred shares, Series J preferred shares, Series K preferred
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
Silence Therapeutics plc (“Silence” or the “Company”) (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today presented additional data
UDR Declares Quarterly Dividends
UDR, Inc. (NYSE: UDR), a leading multifamily real estate investment trust, today announced that its Board of Directors declared a regular quarterly dividend on its common stock for the second
EPR Properties Declares Monthly Dividend for Common Shareholders and Quarterly Dividends for Preferred Shareholders
EPR Properties (NYSE:EPR) today announced that its Board of Trustees has declared its monthly cash dividend to common shareholders. The dividend of $0.295 per common share is payable July 15, 2025
Element Solutions Inc to Participate in Wolfe Research 2nd Annual Materials of the Future Conference
Element Solutions Inc (NYSE: ESI) announced today that Benjamin Gliklich, Chief Executive Officer, will participate in a fireside chat and Q&A session at the Wolfe Research 2nd Annual Materials of
Granite Selected for Tahoe Cedars Water Reconstruction Project
Granite (NYSE:GVA) has been selected by the Tahoe City Public Utility District (TCPUD) for the approximately $3 million preconstruction portion of the Tahoe Cedars Water Reconstruction Project
Mellany Bagtas joins UBS as a Financial Advisor in New York City
UBS Wealth Management US today announced that Mellany Bagtas has joined the firm as a Financial Advisor in New York City. She will be based out of the firm’s 299 Park Avenue office and will report
Nutrien Announces Mark Thompson as a Speaker at the 2025 Wolfe Research Materials of the Future Conference
Nutrien Ltd. (TSX and NYSE: NTR) announced today that Mr. Mark Thompson, Nutrien’s Executive Vice President and Chief Financial Officer, will be speaking at the Wolfe Research Materials of the
GenSight Biologics Reaches Agreement with ANSM for Opening of LUMEVOQ® Named Early Access Program (AAC) in France
Regulatory News:
GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing
European Aerospace, Defense Firms Adopt AI to Compete
Aerospace and technology enterprises in Europe are rapidly integrating AI and other advanced technologies into next-generation systems, driven partly by European Union (EU) initiatives to foster
“Commitment to Our Communities:” Exelon Steps in to Provide $50 Million Customer Relief Fund for Customers Struggling with Higher Energy Supply Costs
Exelon (Nasdaq: EXC) today announced a $50 million Customer Relief Fund to help low- and middle-income (LMI) customers struggling as energy supply costs escalate this summer. Exelon’s local energy
Fuller, Smith & Turner PLC: Transaction in own shares
Carrefour and VusionGroup Test a New Generation of Connected Stores with EdgeSense
Carrefour, one of the world’s leading food retailers, announces a partnership with VusionGroup to launch a new generation of connected stores, based on EdgeSense and Captana technologies to
Apple Hospitality REIT Announces Dates for Second Quarter 2025 Earnings Release and Conference Call
Apple Hospitality REIT, Inc. (NYSE: APLE) (the “Company” or “Apple Hospitality”) today announced that it plans to report second quarter 2025 financial results after the market closes on Wednesday
Registration Now Open for ICMI’s Contact Center Expo 2025
ICMI’s Contact Center Expo, which brings contact center industry professionals together to tackle the challenges and opportunities that will enable positive growth and change in the industry, today



